Search for: "DURA-BOND DEVELOPMENT, INC."
Results 1 - 2
of 2
Sorted by Relevance
|
Sort by Date
11 Nov 2021, 2:07 pm
SCA loss mitigation will limit unfavorable development overhangs of more current SCA vintages on future and potential ESG-related claims. [read post]
23 May 2008, 1:03 am
- Generic manufacturers aggressively promote expensive doxofylline over price controlled equivalent theophylline: (Spicy IP), Middle East – Ranbaxy strengthens presence in Middle East region: (GenericsWeb), Scotland: Future funding of stem cell companies in Scotland dependent on EPO Enlarged Board of Appeals’ decision on stem cell patentability: (IP finance), South Africa: More on AIDS/access debate - Patrick Bond article on Thabo Mbeki’s AIDS policy: (Afro-I [read post]
